National Health Act 1953 Determination under section 93 Pharmaceutical benefits supplied by medical practitioners (No. PB 57 of 2007) (Cth)

Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)

as amended

made under section 93 of the

National Health Act 1953

This compilation was prepared on 1 October 2009
taking into account amendments up to PB 91 of 2009

Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra

Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)

Commencement [see Note 1]

1.       This instrument commences on 1 August 2007.

Repeal

2. Determination No. PB 35 of 2006 under section 93 of the National Health Act 1953, made on 26 July 2006 with effect from 1 August 2006, is repealed.

Pharmaceutical benefits

3.       A pharmaceutical benefit which has a listed drug in a form mentioned in the Schedule is a pharmaceutical benefit which a medical practitioner is authorised to supply.

Maximum quantity or number of units

4. The maximum quantity or number of units of a pharmaceutical benefit which may be obtained by a medical practitioner in any period of one month is the quantity or number of units mentioned in the Schedule under the column “maximum quantity” for the listed drug in the form mentioned less the quantity or number of units of the pharmaceutical benefit previously obtained in accordance with section 93 of the Act and still in the possession of the medical practitioner.

Adrenaline	Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)	5
Atropine	Injection containing atropine sulfate 600 micrograms in 1 mL	10
Benztropine	Injection containing benztropine mesylate 2 mg in 2 mL	5
Benzylpenicillin	Powder for injection 600 mg (as sodium)	10
OR
Procaine Penicillin	Injection 1.5 g in disposable syringe	5
Benzylpenicillin	Powder for injection 3 g (as sodium)	1
Chlorpromazine	Injection containing chlorpromazine hydrochloride 50 mg in 2 mL	10
OR
Haloperidol	Injection 5 mg in 1 mL	10
Clonazepam	Oral liquid 2.5 mg per mL, 10 mL	1
Dexamethasone	Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL	5
OR
Hydrocortisone	Injection 100 mg (as sodium succinate) with 2 mL solvent	2
OR
Hydrocortisone	Injection 250 mg (as sodium succinate) with 2 mL solvent	1
Diazepam	Injection 10 mg in 2 mL	5
Dihydroergotamine	Injection containing dihydroergotamine mesylate 1 mg in 1 mL	5
Diphtheria and tetanus vaccine, adsorbed, diluted for adult use	Injection 0.5 mL in pre-filled syringe	20
Frusemide	Injection 20 mg in 2 mL	5
Glucagon	Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe	1
Glyceryl Trinitrate	Sublingual spray (pump pack) 400 micrograms per dose, 200 doses	1
Hyoscine	Injection containing hyoscine butylbromide 20 mg in 1 mL	5
Lignocaine	Injection containing lignocaine hydrochloride 100 mg in 5 mL	5
Metoclopramide	Injection containing metoclopramide hydrochloride 10 mg in 2 mL	10
OR
Prochlorperazine	Injection containing prochlorperazine mesylate 12.5 mg in 1 mL	10
Morphine	Injection containing morphine sulfate 15 mg in 1 mL	5
OR
Morphine	Injection containing morphine sulfate 30 mg in 1 mL	5
Naloxone	Injection containing naloxone hydrochloride 2 mg in 5 mL disposable injection set	2
Promethazine	Injection containing promethazine hydrochloride 50 mg in 2 mL	10
Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)	1
OR
Salbutamol	Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30	1
Salbutamol	Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30	1
Terbutaline	Injection containing terbutaline sulfate 500 micrograms in 1mL	5
Tramadol	Injection containing tramadol hydrochloride 100 mg in 2 mL	5
Verapamil	Injection containing verapamil hydrochloride 5 mg in 2 mL	5

Notes to the Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)

Note 1

The Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007) (in force under section 93 of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title	Date of FRLI Registration	Date of commencement	Application, saving or transitional provisions
PB 57 of 2007	31 July 2007 (see F2007L02403)	1 Aug 2007
PB 72 of 2007	12 Sept 2007 (see F2007L03623)	1 Oct 2007	—
PB 63 of 2008	11 June 2008 (see F2008L02053)	1 July 2008	—
PB 91 of 2009	17 Sept 2009 (see F2009L03541)	1 Oct 2009	—

Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted
Provision affected	How affected
The Schedule
The Schedule........................	am. PB 72 of 2007; PB 63 of 2008; PB 91 of 2009